Table 2.
Susceptibility of different Blastocystis genotypes to different drug formulations and doses
| Group | No. (%) of mice harboring different genotypes | |||
|---|---|---|---|---|
| Genotype I | Genotype II | Genotype III | Genotype IV | |
| 1 (Infected non-treated) | 10 (100) | 10 (100) | 10 (100) | 10 (100) |
| 2 (MTZ 10 mg/kg) | 7 (70) | 9 (90) | 10 (100) | 8 (80) |
| 3A (AVA 20 mg/kg) | 7 (70) | 10 (100) | 9 (90) | 8 (80) |
| 3B (AVA 40 mg/kg) | 3 (30) | 6 (60) | 7 (70) | 4 (40) |
| 4A (MTZ 10 mg/kg & AVA 20 mg/kg) | 2 (20) | 3 (30) | 4 (40) | 3 (30) |
| 4B (MTZ 10 mg/kg & AVA 40 mg/kg) | 0 (0) | 0 (0) | 1 (10) | 2 (20) |
| Total (n=50) | 29 (58) | 38 (76) | 41 (82) | 35 (70) |